{"doc_key": "sents_context_OR_False", "dataset": "ace05", "sentences": [["In", "fact", ",", "the", "immunostimulatory", "potential", "of", "DNA", "and", "RNA", "molecules", "was", "observed", "before", "the", "concept", "of", "PAMPs", "and", "PRRs", "was", "first", "mentioned", "9,10,11", "."], ["Dedicated", "sensors", "distinguish", "self", "from", "non-self", "either", "based", "on", "a", "particular", "structure", "of", "the", "viral", "nucleic", "acids", "or", "due", "to", "a", "subcellular", "localization", "that", "does", "not", "occur", "in", "the", "healthy", "host", "cell", "reviewed", "in", "12", "."], ["Twice", "RTPCR", "assay", "for", "SARSCoV2", "was", "negative", ",", "and", "he", "was", "discharged", "from", "the", "hospital", "on", "7", "March", "day", "22", "of", "illness", "."], ["The", "patients", "course", "as", "reflected", "by", "the", "laboratory", "data", "showed", "that", "his", "CRP", "levels", "gradually", "decreased", "after", "admission", "."], ["However", ",", "his", "ferritin", "level", "worsened", "once", "and", "gradually", "improved", "after", "starting", "lopinavirritonavir", "and", "adding", "favipiravir", "."], ["Several", "fecal", "isolatesE.", "coli", ",", "Clostridium", "perfringens", "type", "A", ",", "and", "Campylobacter", "spp.are", "normal", "intestinal", "flora", "."], ["Therefore", "diagnostic", "laboratories", "should", "clearly", "indicate", "normal", "bacterial", "growth", "in", "fecal", "culture", "samples", ",", "if", "the", "cultured", "bacteria", "can", "not", "be", "distinguished", "from", "normal", "flora", "by", "identification", "of", "species", ",", "specific", "virulence", "factors", "or", "correlated", "markers", ",", "or", "clear", "demonstration", "of", "overgrowth.1", "When", "enterotoxigenic", "E.", "coli", "or", "Salmonella", "is", "isolated", ",", "susceptibility", "testing", "may", "provide", "a", "useful", "guide", "for", "treatment", "decisions", "and", "antimicrobial", "drug", "selection", "."], ["Some", "patients", "had", "rheumatoid", "arthritis", "flares", "due", "to", "restricted", "access", "to", "health", "care", "during", "the", "initial", "COVID-19", "pandemic", ",", "and", "interrupting", "methotrexate", "treatment", "might", "risk", "destabilising", "disease", "control", "."], ["Nonetheless", ",", "we", "feel", "that", "the", "available", "evidence", "merits", "individualised", "discussions", "with", "patients", "with", "well-controlled", "disease", "regarding", "the", "potential", "benefits", "and", "risks", "of", "omission", "of", "12", "doses", "of", "methotrexate", ",", "influenza", "vaccine", "efficacy", ",", "and", "perhaps", "COVID-19", "vaccination", "when", "available", "."], ["Initially", ",", "it", "was", "believed", "that", "the", "COVID-19", "pandemic", "originated", "at", "the", "Huanan", "Seafood", "Wholesale", "Market", "located", "in", "Wuhan", ",", "China", ",", "where", "farm", "animals", ",", "bats", ",", "and", "snakes", "were", "also", "sold", "8", "this", "is", "still", "believed", "by", "many", "people", "."], ["Approximately", "half", "of", "the", "initial", "cases", "were", "exposed", "to", "the", "seafood", "market", "however", ",", "the", "first", "two", "identified", "cases", "did", "not", "visit", "the", "seafood", "market", "9", "."], ["Viral", "RNA", "was", "found", "in", "environmental", "samples", "from", "the", "wet", "market", ",", "such", "as", "surfaces", "10", "."], ["Since", "similar", "studies", "had", "not", "been", "performed", "with", "MERS-CoV", ",", "we", "generated", "a", "transgenic", "mouse", "with", "a", "humanized", "MERS-CoV", "receptor", "dipeptidyl", "peptidase", "4", ",", "hDPP4", "and", "deleted", "for", "carboxylesterase", "1c", "Ces1c", "to", "improve", "the", "pharmacokinetics", "of", "nucleotide", "prodrugs", "such", "that", "it", "better", "approximates", "the", "drug", "exposure", "profile", "in", "humans22", "."], ["Here", ",", "we", "show", "that", "RDV", "provides", "superior", "antiviral", "activity", "against", "MERS-CoV", "in", "vitro", "and", "in", "vivo", "as", "compared", "with", "LPVRTV-IFNb", "."], ["In", "addition", ",", "RDV", "was", "the", "only", "therapeutic", "treatment", "to", "significantly", "reduce", "pulmonary", "pathology", "."], ["Although", "a", "readily", "available", "biofluid", "rich", "in", "cells", "and", "nucleic", "acids", ",", "urine", "has", "been", "underutilized", "for", "the", "development", "of", "biomarkers", "in", "sepsis", "."], ["Previous", "studies", "have", "shown", "diagnostic", "and", "prognostic", "potential", "of", "urine", "messenger", "RNA", "and", "micro", "RNA", "in", "identifying", "acute", "and", "chronic", "graft", "rejection", "in", "kidney", "transplant", "recipients", "18", ",", "49", ",", "50", "and", "in", "diagnosis", "and", "risk", "stratification", "of", "urologic", "malignancies", "51", ",", "52", "."], ["Unlike", "blood", ",", "urine", "can", "reflect", "the", "kidney", "response", "in", "sepsis", ",", "which", "shows", "damage", "associated", "with", "oxidative", "stress", ",", "hypoxia", ",", "and", "inflammation", "leading", "to", "cell", "death", "and", "epithelial-to-mesenchymal", "tissue", "remodeling", "53", "."], ["The", "benchmark", "tests", "show", "that", "CB-Dock", "outperforms", "other", "state-of-the-art", "blind", "docking", "tools", "in", "terms", "of", "predicting", "binding", "sites", "and", "binding", "conformations", "."], ["This", "performance", "is", "attributed", "to", "the", "curvature-based", "cavity", "detection", "that", "precisely", "narrows", "down", "the", "docking", "space", "as", "well", "as", "the", "optimized", "parameters", "for", "AutoDock", "Vina", "."], ["Some", "shortcomings", "of", "CB-Dock", "were", "also", "observed", "in", "the", "test", "."], ["At", "the", "end", "of", "the", "second", "PDSA", "cycle", ",", "the", "teaching", "sessions", "continued", "to", "demonstrate", "positive", "pre-and-post", "session", "change", "scores", "."], ["However", ",", "the", "reach", "of", "the", "programme", "had", "not", "improved", "."], ["While", "waiting", "for", "definitive", "confirmation", "of", "sarilumab", "efficacy", "in", "patients", "with", "severe", "COVID-19", "from", "ongoing", "randomised", "trials", ",", "this", "last", "finding", "may", "acquire", "particular", "relevance", "in", "settings", "overwhelmed", "by", "COVID-19", "outbreak", "and", "in", "shortage", "of", "ICU", "resources", "whereby", "prolonging", "survival", "may", "allow", "buying", "time", "to", "grant", "critical", "patients", "access", "to", "life-saving", "ICU", "or", "experimental", "treatments", "."], ["Second", ",", "the", "rate", "of", "severe", "secondary", "infectionsa", "possible", "major", "safety", "concern", "which", "might", "be", "expected", "during", "IL-6-blocking", "treatmentswas", "not", "increased", "in", "sarilumab-treated", "patients", "as", "compared", "with", "those", "receiving", "standard", "of", "care", "."], ["Third", ",", "the", "time", "to", "clinical", "improvement", "in", "patients", "with", "17", "of", "consolidated", "lung", "was", "significantly", "shorter", "after", "sarilumab", "infusion", "than", "after", "standard", "treatment", "."], ["High-fat", "consumption", "of", "cholesterol", ",", "processed", "oils", "and", "saturated", "fats", "will", "decrease", "immunity", ",", "leaving", "you", "vulnerable", "to", "viral", "infections", "68", "."], ["Studies", "have", "shown", "that", "a", "diet", "containing", "reduced", "saturated", "fat", "and", "cholesterol", "led", "to", "manipulation", "of", "lipid", "metabolism", "in", "monkeys", ",", "which", "in", "turn", "provided", "significant", "benefits", "by", "slowing", "down", "simian", "immunodeficiency", "virus", "disease", "progression", "69", "."], ["Furthermore", ",", "reducing", "fat", "intake", "will", "decrease", "serum", "angiotensin-converting", "enzyme", "ACE", "levels", "70", "and", "may", ",", "therefore", ",", "decrease", "ones", "risk", "factor", "for", "Covid-19", "by", "decreasing", "the", "number", "of", "binding", "sites", "for", "SARS-CoV-2", "in", "our", "respiratory", "and", "pulmonary", "tissues", "."], ["This", "idea", "is", "also", "supported", "by", "Fig.", "1", "in", "which", "the", "density", "of", "the", "Bayesian", ",", "MinKL", ",", "and", "MaxKL", "divergences", "are", "depicted", "for", "each", "one", "of", "the", "networks2", "."], ["On", "it", "we", "can", "see", "the", "similarities", "between", "the", "densities", "of", "these", "three", "values", "of", "course", "the", "MinKL", "density", "is", "a", "bit", "biased", "to", "the", "left", "and", "MaxKL", "density", "to", "the", "right", ",", "being", "the", "Bayesian", "density", "in", "the", "middle", ",", "but", "with", "very", "small", "differences", "."], ["This", "again", "supports", "the", "idea", "that", "all", "the", "computed", "models", "should", "be", "considered", "as", "result", "of", "the", "learning", "process", "."], ["Major", "changes", "in", "the", "diagnosis", "of", "viral", "infections", "occurred", "in", "the", "1990s", ",", "with", "the", "advent", "of", "more", "sensitive", "molecular", "techniques", ",", "such", "as", "enzymelinked", "immunosorbent", "assays", "ELISAs", "and", "polymerase", "chain", "reaction", "PCR", "in", "particular", "."], ["Molecular", "techniques", ",", "with", "their", "advantages", "of", "greater", "sensitivity", "and", "the", "capacity", "to", "process", "large", "numbers", "of", "samples", "easily", ",", "replaced", "TEM", "in", "many", "areas", "of", "virological", "diagnosis", "."], ["Our", "analysis", "resulted", "in", "successful", "identification", "of", "13", "viral", "structural", "proteins", "and", "18", "host-incorporated", "proteins", "."], ["Moreover", ",", "incorporation", "of", "two", "host", "proteins", "in", "purified", "virions", "was", "verified", "by", "Western", "blot", "analysis", "using", "available", "immunological", "reagents", "."], ["In", "addition", "to", "their", "antiviral", "activity", ",", "IFNs", "show", "an", "immunomodulatory", "capability", "type", " ", "interferons", "can", "enhance", "natural", "killer", "NK-cell", "cytotoxicity", ",", "enhance", "the", "expression", "of", "major", "histocompatibility", "complex", " ", "proteins", ",", "as", "well", "as", "promote", "IFN", "production", "and", "the", "proliferation", "of", "NK", "cells", "and", "macrophages", "De", "Andrea", "et", "al.", ",", "2002", ",", "Goodbourn", "et", "al.", ",", "2000", ",", "Sen", ",", "2001", "."], ["IFN-", "in", "conjunction", "with", "corticosteroids", "were", "shown", "to", "improve", "oxygen", "saturation", "and", "facilitate", "more", "rapid", "resolution", "of", "radiographic", "lung", "abnormalities", "in", "SARS", "infection", "Loutfy", "et", "al.", ",", "2003", "."], ["A", "study", "using", "a", "MERS-CoV", "infection", "mouse", "model", "indicated", "that", "early", "application", "of", "exogenous", "IFN-", "facilitated", "virus", "clearance", "and", "protected", "against", "fatal", "lung", "infection", ",", "while", "delayed", "IFN-", "administration", "tended", "to", "elevate", "damaging", "proinflammatory", "cytokine", "responses", "and", "led", "to", "deleterious", "outcomes", "Channappanavar", "et", "al.", ",", "2019", "."], ["Circulating", "anti-Ad", "antibodies", "have", "an", "immediate", "impact", "on", "the", "therapeutic", "efficiency", "besides", "significantly", "attenuating", "vector-mediated", "gene", "transfer", "efficiency", "37", ",", "they", "also", "have", "been", "shown", "to", "worsen", "vector", "toxicity", "38,39", "."]], "predicted_ner": [[], [[26, 26, "PER", 17.8384, 1.0], [28, 28, "PER", 17.8177, 1.0], [30, 30, "PER", 2.8739, 0.9452], [55, 55, "LOC", 0.1268, 0.5178], [56, 56, "LOC", 1.6136, 0.5985]], [[70, 70, "PER", 20.1148, 1.0], [75, 75, "FAC", 18.5881, 1.0]], [[85, 85, "PER", 17.1313, 1.0], [95, 95, "PER", 29.3627, 1.0]], [[105, 105, "PER", 31.3321, 1.0]], [], [[139, 139, "PER", 5.9812, 0.9389]], [[204, 204, "PER", 20.6375, 1.0]], [[234, 234, "PER", 5.8832, 0.9816], [244, 244, "PER", 20.2217, 1.0]], [[285, 288, "ORG", 5.1753, 0.9421], [291, 291, "GPE", 10.8135, 1.0], [293, 293, "GPE", 18.7961, 1.0], [295, 295, "FAC", 7.1654, 0.9963], [313, 313, "PER", 11.5727, 1.0]], [], [], [[369, 369, "PER", 6.7819, 0.9849]], [[411, 411, "PER", 4.8149, 0.9027]], [], [], [[480, 480, "PER", 3.6155, 0.9712]], [], [[553, 553, "VEH", 11.9926, 1.0]], [], [[599, 599, "VEH", 6.9862, 0.5008]], [], [], [[648, 648, "PER", 9.3857, 0.9998], [674, 674, "ORG", 18.6323, 1.0], [686, 686, "PER", 11.8766, 0.9999], [690, 690, "ORG", 14.0526, 1.0]], [[718, 718, "PER", 12.1388, 1.0], [722, 722, "PER", 13.1372, 1.0]], [[736, 736, "PER", 23.5072, 1.0]], [[768, 768, "PER", 20.2006, 1.0]], [], [[846, 846, "PER", 8.3379, 0.9987]], [[866, 866, "LOC", 2.841, 0.9447]], [[884, 884, "PER", 9.5606, 0.9976], [917, 917, "LOC", 4.9382, 0.9904]], [[938, 938, "PER", 15.495, 1.0]], [], [[989, 989, "ORG", 0.7048, 0.6597], [1009, 1009, "LOC", 8.3719, 0.9998]], [[1014, 1014, "PER", 21.4261, 1.0]], [[1035, 1035, "LOC", 0.6142, 0.6388]], [[1097, 1099, "ORG", 1.9443, 0.8606], [1104, 1104, "ORG", 0.2844, 0.5596], [1110, 1110, "PER", 5.0204, 0.9847]], [[1137, 1138, "ORG", 0.6632, 0.6509]], [[1171, 1171, "ORG", 3.8434, 0.935], [1184, 1185, "ORG", 3.6574, 0.9743]], []], "predicted_relations": [[], [], [[70, 70, 75, 75, "PHYS", 7.267, 0.9993]], [], [], [], [], [], [], [[285, 288, 291, 291, "PART-WHOLE", 4.6768, 0.9041], [291, 291, 293, 293, "PART-WHOLE", 6.0163, 0.9976]], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []]}
